| Dr Loren Everton Little, MD | |
|
2090 E Flamingo Rd, Suite 200, Las Vegas, NV 89119-5116 | |
| (702) 733-9271 | |
| (702) 733-1556 |
| Full Name | Dr Loren Everton Little |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 57 Years |
| Location | 2090 E Flamingo Rd, Las Vegas, Nevada |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205857075 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 2972 (Nevada) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Nevada Eye Care Professionals Little And Stein Ltd | 8628057593 | 4 |
News Archive
More than 80 percent of all waste from Pennsylvania's oil and gas drilling operations stays inside the state, according to a new study that tracks the disposal locations of liquid and solid waste from these operations across 26 years.
"The Board of the Global Fund to Fight AIDS, Tuberculosis and Malaria approved an action plan Monday in response to recommendations made recently by the High-Level Independent Review Panel on Fiduciary Controls and Oversight Mechanism (HLP)," the Center for Global Health Policy's "Science Speaks" blog reports, adding, "The board stated that it accepts the underlying analysis made by the panel and that it 'presents a compelling case for a rapid and urgent transformation of the Global Fund.'"
BioCryst Pharmaceuticals, Inc. today announced that it is offering to sell, subject to market and other conditions, 5,000,000 shares of its common stock pursuant to an effective shelf registration statement in an underwritten public offering.
More than 100 million people in Europe are affected by arthritis / rheumatism, making it Europe's most widespread chronic disease. The condition can have serious consequences, ranging from severe pain to loss of mobility, and delays in diagnosis and treatment have been shown to increase the risk of further joint damage.
Quotient Clinical, the Translational Pharmaceutics Company, has announced a significant expansion of its pharmaceutical sciences capabilities, doubling capacity through the acquisition of a second GMP manufacturing facility and the construction of new formulation development and pharmaceutical analysis laboratories.
› Verified 6 days ago
| Entity Name | Nevada Eye Care Professionals Little & Stein Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1730106824 PECOS PAC ID: 8628057593 Enrollment ID: O20040714001516 |
News Archive
More than 80 percent of all waste from Pennsylvania's oil and gas drilling operations stays inside the state, according to a new study that tracks the disposal locations of liquid and solid waste from these operations across 26 years.
"The Board of the Global Fund to Fight AIDS, Tuberculosis and Malaria approved an action plan Monday in response to recommendations made recently by the High-Level Independent Review Panel on Fiduciary Controls and Oversight Mechanism (HLP)," the Center for Global Health Policy's "Science Speaks" blog reports, adding, "The board stated that it accepts the underlying analysis made by the panel and that it 'presents a compelling case for a rapid and urgent transformation of the Global Fund.'"
BioCryst Pharmaceuticals, Inc. today announced that it is offering to sell, subject to market and other conditions, 5,000,000 shares of its common stock pursuant to an effective shelf registration statement in an underwritten public offering.
More than 100 million people in Europe are affected by arthritis / rheumatism, making it Europe's most widespread chronic disease. The condition can have serious consequences, ranging from severe pain to loss of mobility, and delays in diagnosis and treatment have been shown to increase the risk of further joint damage.
Quotient Clinical, the Translational Pharmaceutics Company, has announced a significant expansion of its pharmaceutical sciences capabilities, doubling capacity through the acquisition of a second GMP manufacturing facility and the construction of new formulation development and pharmaceutical analysis laboratories.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Loren Everton Little, MD 2090 E Flamingo Rd, Suite 200, Las Vegas, NV 89119-5116 Ph: (702) 733-9271 | Dr Loren Everton Little, MD 2090 E Flamingo Rd, Suite 200, Las Vegas, NV 89119-5116 Ph: (702) 733-9271 |
News Archive
More than 80 percent of all waste from Pennsylvania's oil and gas drilling operations stays inside the state, according to a new study that tracks the disposal locations of liquid and solid waste from these operations across 26 years.
"The Board of the Global Fund to Fight AIDS, Tuberculosis and Malaria approved an action plan Monday in response to recommendations made recently by the High-Level Independent Review Panel on Fiduciary Controls and Oversight Mechanism (HLP)," the Center for Global Health Policy's "Science Speaks" blog reports, adding, "The board stated that it accepts the underlying analysis made by the panel and that it 'presents a compelling case for a rapid and urgent transformation of the Global Fund.'"
BioCryst Pharmaceuticals, Inc. today announced that it is offering to sell, subject to market and other conditions, 5,000,000 shares of its common stock pursuant to an effective shelf registration statement in an underwritten public offering.
More than 100 million people in Europe are affected by arthritis / rheumatism, making it Europe's most widespread chronic disease. The condition can have serious consequences, ranging from severe pain to loss of mobility, and delays in diagnosis and treatment have been shown to increase the risk of further joint damage.
Quotient Clinical, the Translational Pharmaceutics Company, has announced a significant expansion of its pharmaceutical sciences capabilities, doubling capacity through the acquisition of a second GMP manufacturing facility and the construction of new formulation development and pharmaceutical analysis laboratories.
› Verified 6 days ago
Dr. Jason Craig Wickens, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 653 N Town Center Dr Ste 518, Las Vegas, NV 89144 Phone: 702-369-0200 Fax: 702-243-8383 | |
Dr. Surjeet Singh, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2020 Wellness Way Ste 401, Las Vegas, NV 89106 Phone: 702-896-6043 Fax: 702-896-9591 | |
Peter Lloyd Hildebrand, M.D. Ophthalmology Medicare: Medicare Enrolled Practice Location: 2020 Wellness Way Ste 402, Las Vegas, NV 89106 Phone: 702-485-5000 Fax: 702-485-5005 | |
Dr. Brett D Brimhall, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 6850 N Durango Dr, 110, Las Vegas, NV 89149 Phone: 702-263-2020 Fax: 702-396-0287 | |
Helga F Pizio, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2020 Wellness Way Ste 402, Las Vegas, NV 89106 Phone: 702-485-5000 Fax: 702-485-5001 | |
Grace S Shin, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 6028 S Fort Apache Rd Ste 101, Las Vegas, NV 89148 Phone: 702-896-2020 Fax: 702-896-2025 | |
Dr. Jeffrey L. Hart, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 5871 W. Craig Rd., Las Vegas, NV 89130 Phone: 702-724-2020 Fax: 702-724-2800 |